pteridines has been researched along with Diabetic Nephropathies in 2 studies
Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Wang, Z | 1 |
| Liu, R | 1 |
| Li, Z | 1 |
| Lin, J | 1 |
| Wojciechowicz, ML | 1 |
| Huang, J | 1 |
| Lee, K | 1 |
| Ma'ayan, A | 1 |
| He, JC | 1 |
| Terker, AS | 1 |
| Zhang, MZ | 1 |
| Harris, RC | 1 |
2 other studies available for pteridines and Diabetic Nephropathies
| Article | Year |
|---|---|
Connectivity Mapping Identifies BI-2536 as a Potential Drug to Treat Diabetic Kidney Disease.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Kidney; Mice; Pharmaceutical Preparations; Pteri | 2021 |
Staying Connected: Transcriptomics in the Search for Novel Diabetic Kidney Disease Treatments.
Topics: Diabetes Mellitus; Diabetic Nephropathies; Humans; Pharmaceutical Preparations; Pteridines; Transcri | 2021 |